Everardo Cobos to Lung Neoplasms
This is a "connection" page, showing publications Everardo Cobos has written about Lung Neoplasms.
Connection Strength
0.358
-
Mann BK, D'Assumpcao C, Okumoto L, Aboaid S, Abooed A, Cobos E, Heidari A. Spurious Presentation of Pulmonary Kaposi Sarcoma as Unresolved Pneumonia Led to Fatal Outcome. J Investig Med High Impact Case Rep. 2023 Jan-Dec; 11:23247096231208996.
Score: 0.134
-
Mirandola L, Figueroa JA, Phan TT, Grizzi F, Kim M, Rahman RL, Jenkins MR, Cobos E, Jumper C, Alalawi R, Chiriva-Internati M. Novel antigens in non-small cell lung cancer: SP17, AKAP4, and PTTG1 are potential immunotherapeutic targets. Oncotarget. 2015 Feb 20; 6(5):2812-26.
Score: 0.078
-
Chiriva-Internati M, Pandey A, Saba R, Kim M, Saadeh C, Lukman T, Chiaramonte R, Jenkins M, Cobos E, Jumper C, Alalawi R. Cancer testis antigens: a novel target in lung cancer. Int Rev Immunol. 2012 Oct; 31(5):321-43.
Score: 0.066
-
Chiriva-Internati M, Grizzi F, Weidanz JA, Ferrari R, Yuefei Y, Velez B, Shearer MH, Lowe DB, Frezza EE, Cobos E, Kast WM, Kennedy RC. A NOD/SCID tumor model for human ovarian cancer that allows tracking of tumor progression through the biomarker Sp17. J Immunol Methods. 2007 Apr 10; 321(1-2):86-93.
Score: 0.045
-
Jumper C, Cobos E, Lox C. Determination of the serum matrix metalloproteinase-9 (MMP-9) and tissue inhibitor of matrix metalloproteinase-1 (TIMP-1) in patients with either advanced small-cell lung cancer or non-small-cell lung cancer prior to treatment. Respir Med. 2004 Feb; 98(2):173-7.
Score: 0.036